JNJ-78278343

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for JNJ-78278343, covering 2026-02-17 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer [Phase 1]